Sampson Pharmaceutical Private Limited
About Sampson Pharmaceutical Private Limited
Data last updated:
Sampson Pharmaceutical Private Limited is a private limited company based in Kalyan, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 25 July 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U47721MH2023PTC407353.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nigam Kumar and Neeraj Kumar Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kalyan, Maharashtra.
Company details
Contact details
Sampson Pharmaceutical Private Limited's registered office is in Kalyan, Maharashtra.
- Registered AddressFlat No.1001 Bldg No. 19, Papyrus Regency Ananta, Kalyan, Maharashtra, India – 421203
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sampson Pharmaceutical Private Limited
FY 2025 filings availableFinancial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Sampson Pharmaceutical Private Limited, buy the company report.
Board of directors of Sampson Pharmaceutical Private Limited
Sampson Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nigam Kumar | Director | 25 Jul 2023 | 3 Years 2 Months | Current |
| Neeraj Kumar Sharma | Director | 25 Jul 2023 | 3 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Sampson Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sampson Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sampson Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sampson Pharmaceutical Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Neeraj Kumar Sharma was appointed as Director on 25 Jul 2023.
Frequently asked questions
Sampson Pharmaceutical is an active private limited company based in Kalyan, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 25 July 2023 (3+ years old) and is registered under CIN U47721MH2023PTC407353.
Sampson Pharmaceutical has 2 current directors:
- Nigam Kumar - Director
- Neeraj Kumar Sharma - Director
The latest financial statements of Sampson Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Sampson Pharmaceutical is U47721MH2023PTC407353. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sampson Pharmaceutical was incorporated on 25 July 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
Neeraj Kumar Sharma was appointed as Director on 25 Jul 2023. Nigam Kumar was appointed as Director on 25 Jul 2023.
The registered office of Sampson Pharmaceutical is at Flat No.1001 Bldg No. 19, Papyrus Regency Ananta, Kalyan, Maharashtra, India – 421203.
Sampson Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sampson Pharmaceutical can be reached at its registered office: Flat No.1001 Bldg No. 19, Papyrus Regency Ananta, Kalyan, Maharashtra, India – 421203.
Sampson Pharmaceutical is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.